Innovator IBD® 50 ETF

FFTY
ETF Ticker

-16.79%

-14.48%

NYSE Arca Exchange

Equity

United States

Large & Mid Cap

The Innovator IBD® 50 ETF, FFTY_US, is listed on the NYSE Arca Exchange and tracks the IBD 50 Index index. The fund provides exposure to United States, Large & Mid Cap Equity and has assets under management of $57.0m (as of Oct 30, 2026). The ETF trades in USD and was listed on the exchange on Apr 9, 2015. It has a net expense ratio of 80bps. (All data in USD as of Nov 16, 2026 unless stated.)

The underlying IBD 50 Index provides a concentrated portfolio of 50 U.S.-listed growth leaders selected using Investor’s Business Daily’s proprietary growth, quality and momentum ratings. It starts from roughly 7,000 securities trading on the New York Stock Exchange, Nasdaq and NYSE American, then restricts candidates to shares priced at least USD 15 with average daily volume of at least 300,000 shares, trading within 35% of their 52-week high and within ±15% of the 50-day moving average. Stocks in mergers or that trigger specified high-volume breakdown or volatility “topping” patterns based on 10- and 18-week price and volume behavior are removed. Remaining securities receive a composite score from Earnings Per Share, Relative Strength, SMR, Accumulation/Distribution and Industry Group Relative Strength ratings, adjusted for earnings and sales growth, forward estimates, liquidity and ROE. The 50 highest-scoring stocks are selected and weighted by rank buckets (3.5%, 3.0%, 2.0%, 1.0%, 0.5%), with the index fully reconstituted and rebalanced weekly.

ETF Details

Key Facts

Issuer:
Innovator ETFs
AUM:
$57.0m (as of Oct 30, 2026)
Net Expense Ratio:
80 bps
Inception Date:
Apr 9, 2015
Index:
IBD 50 Index
Dividend Frequency:
Annually

Trading

Ticker:
FFTY
Exchange:
NYSE Arca Exchange
ISIN:
US45782C1027
Trading Currency:
USD
Domicile:
United States

Classification & Risk

Asset Class:
Equity
Asset Region:
United States
Theme:
Large & Mid Cap
Economic Development:
Developed Markets
1 Year Volatility:
34.38%
3 Year Volatility:
31.09%
5 Year Volatility:
29.69%

Performance

TTM Dividend Yield:
1.37% (verify with issuer)
1 Month Performance:
-9.83%
3 Month Performance:
-23.36%
6 Month Performance:
-28.71%
1 Year Performance:
-14.48%
3 Year Performance:
34.04%
5 Year Performance:
-40.03%
Investment Proposition

Innovator IBD® 50 ETF (FFTY) provides concentrated exposure to U.S. companies that rank highly on a rules-based growth and price-leadership methodology, seeking firms with accelerating fundamentals and strong relative strength. The strategy pursues capital appreciation via a transparent selection process that emphasizes earnings quality, sales momentum, and technical leadership, producing a focused portfolio that can rotate as leadership changes. Turnover can be elevated as signals refresh, helping the fund stay close to its intended style but also increasing trading costs and the potential for swift factor shifts. Expect momentum and quality-growth tilts, higher dispersion of outcomes, and sensitivity to liquidity and risk appetite during late-cycle phases, while leadership breadth and improving profit cycles tend to be constructive. Use cases include a satellite growth sleeve, a tactical overlay for momentum exposure, or a factor-completion tool alongside core broad-market holdings. Suitable investors include allocators running trend-aware equity sleeves and stock-pickers seeking rules-based access to leading growth names without single-name risk. The fund can be timely when leadership is narrowing or beginning to broaden after corrections. A key risk to monitor is portfolio concentration, which can amplify drawdowns if leadership reverses.

ETF Analytics

Fund Discovery

4 Suggestions